醫療技術和生物製藥領域醫療設備CMO/CDMO市場：依產品類型、服務類型、器材分類和地區分類

醫療技術和生物製藥領域的醫療設備CMO/CDMO市場預計到2026年將達到1,102.272億美元，預計到2033年將達到2717.585億美元。預計從2026年到2033年，該市場將以13.8%的複合年成長率成長。

全球醫療技術和生物製藥器材的合約研發生產機構 (CMO/CDMO) 市場涵蓋高成長和創新醫療設備、診斷器材、藥用醫療設備組合產品以及給藥裝置的合約研發生產服務，以及器材和醫療保健應用領域的合約研發生產服務。 CMO/CDMO 作為外包合作夥伴，為客戶公司提供設計、工程、法規遵循、生產、包裝和物流等方面的支援。

在控制營運和產品開發成本、加快產品上市速度、推出創新產品以及利用專業知識等日益成長的需求驅動下，製藥、醫療設備和生物製藥行業正積極尋求合作夥伴，以外包產品設計、開發和生產。隨著自動注射器、生技藥品給藥裝置、穿戴式醫療設備及相關醫療保健設備的廣泛應用，與合約生產組織 (CMO) 或合約研發生產組織 (CDMO) 建立策略夥伴關係在整個生命科學產業（涵蓋藥物開發、給藥裝置乃至藥器聯合應用）中變得愈發重要。

市場動態

全球醫療技術（MedTech）和生物製藥器材CMO/CDMO市場的發展，主要受器材研發和生產外包模式的日益普及所驅動。隨著連網型設備和醫療技術器材領域的應用不斷成長，許多生命科學公司正積極尋求CMO/CDMO服務，以最佳化產品上市時間、生產效率和成本效益。

然而，市場面臨許多限制因素，包括嚴格的監管障礙、繁瑣的驗證流程以及高品質保護相關的高昂成本。這些市場限制，加上供應鏈瓶頸和利基製造服務產能有限，阻礙了市場發展。儘管如此，創新藥物輸送裝置和穿戴式醫療技術的日益普及，以及新興生命科學公司向策略外包的轉變，將為醫療技術和生物製藥設備領域的CMO/CDMO市場創造新的成長機會。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數，對全球醫療技術和生物製藥設備 CMO/CDMO 市場中的關鍵公司進行了概況介紹：公司概況、產品系列、主要亮點、財務績效和策略。
• 本報告提供的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 這份「全球醫療技術和生物製藥設備 CMO/CDMO 市場」報告旨在為該行業內的各種相關人員提供參考，包括投資者、經銷商、產品製造商、分銷商、新參與企業和金融分析師。
• 相關人員可以透過利用分析全球醫療技術和生物製藥設備 CMO/CDMO 市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 市場機遇
• 監管趨勢
• 產業趨勢

第4章：全球醫療設備CMO/CDMO市場（醫療技術和生物製藥領域）：依產品/器材類型分類，2021-2033年

• 藥品和醫療設備組合產品
• 醫療器材
• 診斷及測試設備及裝置
• 其他產品類型和設備類型

第5章：全球醫療設備CMO/CDMO市場（醫療技術和生物製藥領域）：依服務類型分類，2021-2033年

• 設計、開發及工程服務
• 契約製造
• 供應鏈管理
• 品質與監管
• 其他附加價值服務

第6章：全球醫療設備CMO/CDMO市場（醫療技術和生物製藥領域）：依醫療設備分類，2021-2033年

• 一級
• 二類
• 三級

第7章：全球醫療設備CMO/CDMO市場（醫療技術和生物製藥領域）：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第8章 競爭情勢

• Integer Holdings Corporation
• Jabil Inc.
• Flex Ltd.
• Sanmina Corporation
• Phillips-Medisize
• Nordson MEDICAL
• West Pharmaceutical Services
• Gerresheimer AG
• SteriPack Group
• Nipro Corporation

第9章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第10章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

MedTech & Biopharma Device CMO/CDMO Market is estimated to be valued at USD 110,227.2 Mn in 2026 and is expected to reach USD 271,758.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.

The global MedTech & biopharma device CMO/CDMO market includes contract development and manufacturing services for medical devices, diagnostics, drug-device combination products, and drug delivery devices with high growth and innovation, as well as contract development and manufacturing services for devices and medical and healthcare applications. By functioning as outsourcing partners, CMOs/CDMOs help client companies design, engineer, provide and integrate regulatory, manufacturing, packaging and logistics.

The need to control operational and product development expenses, speed product to market, gain market access for new innovative products and leverage specialized know how is encouraging pharmaceutical, medical device, and biopharmaceutical industries to seek an outsourced product design, development and manufacturing partner solution. Increased usage of autoinjector devices and biologics delivery devices, wearable medicals devices, and associated healthcare devices will require partnerships with strategically positioned CMOs/CDMOs throughout the life science industry, including drug development and delivery device and drug device combinations.

Market Dynamics

The global MedTech & biopharma device CMO/CDMO market is driven by the rising level of outsourcing of device development and manufacturing functions. Adoption of drug device combination products, biologics delivery devices and connected devices for medtech devices is promoting life sciences players to attain CMO/CDMO competency to optimize time-to-market, manufacturing and cost efficiency.

However, a number of constraints are present in the market, such as stringent regulatory barriers, tedious validation process, and high-quality protection cost. These market limitations coupled with the bottlenecks in the supply chain and the limited capacity for niche manufacturing services pose hurdles to the market advancement. Nevertheless, increasing adoption of innovative drug delivery devices and wearable healthcare technologies as well as shift toward strategic outsourcing by emerging life sciences organizations will offer new opportunities for growth in MedTech & biopharma device CMO/CDMO market.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global MedTech & biopharma device CMO/CDMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Integer Holdings Corporation, Jabil Inc., Flex Ltd., Sanmina Corporation, Phillips-Medisize, Nordson MEDICAL, West Pharmaceutical Services, Gerresheimer AG, SteriPack Group, and Nipro Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global MedTech & biopharma device CMO/CDMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global MedTech & biopharma device CMO/CDMO market

Market Segmentation

• Product/Device Type Insights (Revenue, USD Mn, 2021 - 2033)
• Drug-Device Combination Products
• Medical Devices
• Diagnostics and Laboratory Devices/Equipment
• Other Product / Device Types
• Service Type Insights (Revenue, USD Mn, 2021 - 2033)
• Design Development and Engineering Services
• Contract manufacturing
• Supply Chain Management
• Quality and Regulations
• Other Value-Added Services
• Device Class Insights (Revenue, USD Mn, 2021 - 2033)
• Class I
• Class II
• Class III
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Integer Holdings Corporation
• Jabil Inc.
• Flex Ltd.
• Sanmina Corporation
• Phillips-Medisize
• Nordson MEDICAL
• West Pharmaceutical Services
• Gerresheimer AG
• SteriPack Group
• Nipro Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type
  • Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type
  • Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class
  • Global MedTech & Biopharma Device CMO/CDMO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Industry Trends

4. Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Drug-Device Combination Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Medical Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Diagnostics and Laboratory Devices/Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Other Product / Device Types
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Design Development and Engineering Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Contract manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Supply Chain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Quality and Regulations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Other Value-Added Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Class I
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Class II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Class III
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global MedTech & Biopharma Device CMO/CDMO Market, By Region, 2021 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Integer Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jabil Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Flex Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanmina Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Phillips-Medisize
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nordson MEDICAL
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• West Pharmaceutical Services
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SteriPack Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nipro Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us